At ESMO, three studies show promise of antibody-drug conjugates in breast cancer

At ESMO, three studies show promise of antibody-drug conjugates in breast cancer

Source: 
Pharmaforum
snippet: 

The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of cancer researchers just had their own gathering, as breast cancer researchers came together in person for the first time since the start of the pandemic at the ESMO Breast Cancer congress.